Prognostic influence of the liver hanging maneuver for patients with hepatobiliary malignancies who underwent hepatic resections

Eur J Surg Oncol. 2014 Nov;40(11):1540-9. doi: 10.1016/j.ejso.2014.06.013. Epub 2014 Jul 19.

Abstract

Background: Prognostic influences of hepatic transection by an anterior approach using the liver hanging maneuver (LHM) has not been fully clarified.

Methods: We examined 233 patients who underwent major hepatectomy with the LHM (n = 75; hepatocellular carcinoma (HCC) in 35, colorectal liver metastasis (CLM) in 10, intrahepatic cholangiocarcinoma (ICC) in 14 and perihilar bile duct carcinoma (BDC) in 16) or without it (n = 158; HCC in 78, CLM in 21, ICC in 31 and BDC in 28).

Results: In HCC patients, cancer-positive margin rate, blood loss, transection time and prevalence of posthepatectomy ascites in the LHM group were significantly lower than those in the non-LHM group (p < 0.05). In CLM, transection time in the LHM group was significantly lower than that in the non-LHM group (p < 0.05). In BDC patients, amount of blood loss, transection time and prevalence of ascites in the LHM group were significantly lower than those in the non-LHM group (p < 0.05). In CLM patients, tumor recurrence rate in the non-LHM group was significantly higher than that in the LHM group and disease-free survival in the LHM group was significantly better than that in the non-LHM group in CLM patients and, however, this difference was not observed in a large CLM exceeding 5 cm. However, significant differences of posthepatectomy disease-free and overall survivals were not observed in HCC, ICC and BDC patients.

Conclusions: Although advantages of LHM improving surgical records in major anatomical liver resections were clarified, oncological advantages in the long-term survival of LHM was still uncertain in the hepatobiliary malignancies.

Keywords: Hepatectomy; Hepatobiliary malignancies; Liver hanging maneuver; Major anatomic resection; Patient prognosis.

MeSH terms

  • Aged
  • Ascites / complications
  • Bile Duct Neoplasms / complications
  • Bile Duct Neoplasms / surgery*
  • Bile Ducts, Intrahepatic*
  • Blood Loss, Surgical
  • Carcinoma, Hepatocellular / complications
  • Carcinoma, Hepatocellular / surgery*
  • Cholangiocarcinoma / complications
  • Cholangiocarcinoma / surgery*
  • Colorectal Neoplasms / pathology*
  • Disease-Free Survival
  • Female
  • Hepatectomy / methods*
  • Humans
  • Liver Neoplasms / complications
  • Liver Neoplasms / secondary
  • Liver Neoplasms / surgery*
  • Male
  • Middle Aged
  • Neoplasm Recurrence, Local
  • Neoplasm, Residual
  • Operative Time
  • Prognosis
  • Treatment Outcome